Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Linington

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
The American Journal of Pathology|March 25, 2004
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosisMartin Kerschensteiner, Christine Stadelmann, Bigna S Buddeberg, et al.
European Journal of Pharmacology|May 23, 2008
DNA vaccination efficiently induces antibodies to Nogo-A and does not exacerbate experimental autoimmune encephalomyelitisCarole Bourquin, Marjan E van der Haar, David Anz, et al.
Acta Neuropathologica Communications|January 30, 2022
Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelinationSusan L Lindsay, Aleksandra M Molęda, Lindsay M MacLellan, et al.
Journal of Neuropathology and Experimental Neurology|December 31, 2004
Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammationFahmy Aboul-Enein, Jan Bauer, Matthias Klein, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Acta Neuropathologica Communications|December 21, 2019
Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potentialKatja Thümmler, Eran Rom, Thomas Zeis, et al.
Brain : a Journal of Neurology|May 8, 2012
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosisChristina Elliott, Maren Lindner, Ariel Arthur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2015
B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosisChelsea R Parker Harp, Angela S Archambault, Julia Sim, et al.
Annals of Neurology|September 17, 2013
Neurological deficits caused by tissue hypoxia in neuroinflammatory diseaseAndrew L Davies, Roshni A Desai, Peter S Bloomfield, et al.
Experimental Neurology|May 15, 2022
Myelinated axons are the primary target of hemin-mediated oxidative damage in a model of the central nervous systemKarl Baldacchino, William J Peveler, Leandro Lemgruber, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
The American Journal of Pathology|March 25, 2004
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosisMartin Kerschensteiner, Christine Stadelmann, Bigna S Buddeberg, et al.
European Journal of Pharmacology|May 23, 2008
DNA vaccination efficiently induces antibodies to Nogo-A and does not exacerbate experimental autoimmune encephalomyelitisCarole Bourquin, Marjan E van der Haar, David Anz, et al.
Acta Neuropathologica Communications|January 30, 2022
Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelinationSusan L Lindsay, Aleksandra M Molęda, Lindsay M MacLellan, et al.
Journal of Neuropathology and Experimental Neurology|December 31, 2004
Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammationFahmy Aboul-Enein, Jan Bauer, Matthias Klein, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Acta Neuropathologica Communications|December 21, 2019
Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potentialKatja Thümmler, Eran Rom, Thomas Zeis, et al.
Brain : a Journal of Neurology|May 8, 2012
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosisChristina Elliott, Maren Lindner, Ariel Arthur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2015
B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosisChelsea R Parker Harp, Angela S Archambault, Julia Sim, et al.
Annals of Neurology|September 17, 2013
Neurological deficits caused by tissue hypoxia in neuroinflammatory diseaseAndrew L Davies, Roshni A Desai, Peter S Bloomfield, et al.
Experimental Neurology|May 15, 2022
Myelinated axons are the primary target of hemin-mediated oxidative damage in a model of the central nervous systemKarl Baldacchino, William J Peveler, Leandro Lemgruber, et al.
Pageof 7